CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 8-K Event Bylaws or fiscal year change
- 4 Option exercise Director acquired 27,089 shares (option exercise)
- 8-K Event Shareholder vote results
- EFFECT Other Notice of Effectiveness
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-3 Offering Registration Statement
- 8-K Event Executive or director change
- 4 Option exercise Director acquired 27,089 shares (option exercise)
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Planned sale See Remarks sold 165 shares at $0.35 ($58)
Page 8 of 34 · 672 filings